Pandey S C, Isaac L, Davis J M, Pandey G N
Illinois State Psychiatric Institute, University of Illinois College of Medicine, Chicago 60612.
Eur J Pharmacol. 1991 Sep 17;202(2):221-5. doi: 10.1016/0014-2999(91)90297-4.
The effect of chronic and acute treatment with desipramine (DMI) and electroconvulsive shock (ECS) on 5-hydroxytryptamine1A (5-HT1A) receptors was determined in the cortex and the hippocampus brain regions of rats. We observed that chronic treatment with both DMI and ECS significantly decreased 5-HT1A receptors, as determined by [3H]8-hydroxy-2-(di-n-propylamino)tetralin [( 3H]8-OH-DPAT) binding, in the cortex but not in the hippocampus. Acute treatment with DMI or ECS did not significantly alter the 5-HT1A receptors in the cortex. Neither chronic nor acute treatment influenced KD of [3H]8-OH-DPAT binding in the cortex or hippocampus. These results thus suggest that in contrast to the effects on 5-HT2 receptors, tricyclics as well as ECS produce similar effects on 5-HT1A receptors, suggesting that this site may represent a common site of action for antidepressant treatment.
在大鼠的大脑皮层和海马体区域,测定了去甲丙咪嗪(DMI)和电惊厥休克(ECS)的慢性及急性治疗对5-羟色胺1A(5-HT1A)受体的影响。我们观察到,通过[3H]8-羟基-2-(二正丙基氨基)四氢萘([3H]8-OH-DPAT)结合测定,DMI和ECS的慢性治疗均显著降低了大脑皮层中的5-HT1A受体,但在海马体中未降低。DMI或ECS的急性治疗并未显著改变大脑皮层中的5-HT1A受体。慢性和急性治疗均未影响大脑皮层或海马体中[3H]8-OH-DPAT结合的解离常数(KD)。因此,这些结果表明,与对5-HT2受体的影响相反,三环类药物以及ECS对5-HT1A受体产生相似的影响,这表明该位点可能是抗抑郁治疗的共同作用位点。